Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $106.78 Average Target Price from Brokerages
Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) have earned an average recommendation of “Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price […]
